Low Signal

MK-1775

MK-1775 is flagged as low signal because public records show limited public risk signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Program overview

Context

Indication: Adenocarcinoma of the Pancreas

Mechanism: Unknown

Modality: Unknown

Sponsor: University of Michigan Rogel Cancer Center

Scores

Risk-signal summary

Registry: 0/5

Timeline: 1/5

Recruitment burden: 0/5

Results availability: 0/5

Program risk: 0/5

Evidence

Public links

https://clinicaltrials.gov/study/NCT02037230

Linked trials

Trial-level signal details

TrialStatusTimelineResultsBurden
NCT02037230Low Signal (COMPLETED)stale_update_signalLow SignalNone